We’re pleased to announce that we have signed a distribution agreement with Australian Clinical Labs for CNSDose. This partnership marks an important step in expanding access to CNSDose testing across Australia. Through ACL’s national network, CNSDose will be more readily available to clinicians supporting patients with mental health conditions.

We look forward to working closely with the team at ACL to bring this innovation to clinicians and patients nationwide.